Combined Angiotensin Receptor Modulation in the Management of Cardio-Metabolic Disorders
about
Angiotensin A/Alamandine/MrgD Axis: Another Clue to Understanding Cardiovascular PathophysiologySmall-molecule AT2 receptor agonists.Future drug discovery in renin-angiotensin-aldosterone system intervention.Lipotoxicity-Related Hematological Disorders in Obesity.Prolylcarboxypeptidase deficiency is associated with increased blood pressure, glomerular lesions, and cardiac dysfunction independent of altered circulating and cardiac angiotensin II.Chronic administration of the angiotensin type 2 receptor agonist C21 improves insulin sensitivity in C57BL/6 mice
P2860
Combined Angiotensin Receptor Modulation in the Management of Cardio-Metabolic Disorders
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Combined Angiotensin Receptor Modulation in the Management of Cardio-Metabolic Disorders
@ast
Combined Angiotensin Receptor Modulation in the Management of Cardio-Metabolic Disorders
@en
type
label
Combined Angiotensin Receptor Modulation in the Management of Cardio-Metabolic Disorders
@ast
Combined Angiotensin Receptor Modulation in the Management of Cardio-Metabolic Disorders
@en
prefLabel
Combined Angiotensin Receptor Modulation in the Management of Cardio-Metabolic Disorders
@ast
Combined Angiotensin Receptor Modulation in the Management of Cardio-Metabolic Disorders
@en
P2860
P50
P921
P1433
P1476
Combined Angiotensin Receptor Modulation in the Management of Cardio-Metabolic Disorders
@en
P2093
Chiara Recarti
P2860
P2888
P356
10.1007/S40265-015-0509-4
P5008
P577
2015-12-02T00:00:00Z
2016-01-01T00:00:00Z
P5875
P6179
1022775201